REGEN-COV Antibody Cocktail Clinical Outcomes Study in Covid-19 Outpatients
David M. Weinreich(Regeneron (United States)), Lilia Roque-Guerrero, Shazia Ali(Regeneron (United States)), Andrea T. Hooper(Regeneron (United States)), Cynthia X. Pan(Anna Needs Neuroblastoma Answers), Ned Braunstein(Anna Needs Neuroblastoma Answers), Rafia Bhore(Bristol-Myers Squibb (Germany)), Yuhwen Soo(Regeneron (United States)), Thomas DiCioccio(Anna Needs Neuroblastoma Answers), Thomas Norton(Anna Needs Neuroblastoma Answers), Romana Hosain(Anna Needs Neuroblastoma Answers), Jennifer D. Hamilton(Regeneron (United States)), Leah Lipsich(Anna Needs Neuroblastoma Answers), Sumathi Sivapalasingam(Anna Needs Neuroblastoma Answers), Christina J. Perry(Florey Institute of Neuroscience and Mental Health), Bret J. Musser(Regeneron (United States)), Alina Baum(Regeneron (United States)), Haitao Gao(Novartis (United States)), Bari Kowal(Anna Needs Neuroblastoma Answers), Joseph Im(Anna Needs Neuroblastoma Answers), Joseph A. Bocchini(Louisiana State University Health Sciences Center New Orleans), Christos A. Kyratsous(Regeneron (United States)), Diana Rofail(Regeneron (United States)), Hessam Aazami(HOPE Clinic), Neil Stahl(Arthritis and Rheumatism Associates), Gerard Acloque(Unknown), Gary Herman(Regeneron (United States)), George D. Yancopoulos(Regeneron (United States)), Dominique Y. Atmodjo(Regeneron (United States)), Jesus Abraham Simón Campos, Wendy Kampman(Anna Needs Neuroblastoma Answers), Jing Xiao(Dalian Medical University), Mohamed Hussein(Humana (United States)), Yun‐Ji Kim(Anna Needs Neuroblastoma Answers), K. C. Turner(Regeneron (United States)), Adnan Mahmood(Anna Needs Neuroblastoma Answers), Amanda Cook(Harvard University), John D. Davis(Providence College), Kevin Cannon(PMG Research)
Cited by 40
Related Papers
Vascular-specific growth factors and blood vessel formation
|Nature|2000|3.7k
Two Phase 3 Trials of Dupilumab versus Placebo in Atopic Dermatitis
|New England Journal of Medicine|2016|2.1k
REGN-COV2, a Neutralizing Antibody Cocktail, in Outpatients with Covid-19
|New England Journal of Medicine|2020|1.8k
CRISPR-Cas9 In Vivo Gene Editing for Transthyretin Amyloidosis
|New England Journal of Medicine|2021|1.7k